FDA Inspection 900067 — Reproductive Medicine Institute

Reproductive Medicine Institute — FEI 3009383018

The FDA completed an inspection of Reproductive Medicine Institute on October 16, 2014 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 16, 2014
Fiscal Year
2015
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Chicago, IL (United States)